These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18172353)

  • 1. [Pathogenesis and treatment of intestinal Behçet's disease].
    Lee CK; Kim HJ
    Korean J Gastroenterol; 2007 Jul; 50(1):3-8. PubMed ID: 18172353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on the Medical Management of Gastrointestinal Behçet's Disease.
    Lopalco G; Rigante D; Venerito V; Fabiani C; Franceschini R; Barone M; Lapadula G; Galeazzi M; Frediani B; Iannone F; Cantarini L
    Mediators Inflamm; 2017; 2017():1460491. PubMed ID: 28210071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behçet's syndrome: from aetiology to treatment.
    Powell RJ
    Adv Exp Med Biol; 2003; 528():481-6. PubMed ID: 12918749
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of Behçet's disease--an update.
    Kaklamani VG; Kaklamanis PG
    Semin Arthritis Rheum; 2001 Apr; 30(5):299-312. PubMed ID: 11303303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of recurrent perforating intestinal ulcers with thalidomide in Behçet's disease.
    Sayarlioglu M; Kotan MC; Topcu N; Bayram I; Arslanturk H; Gul A
    Ann Pharmacother; 2004 May; 38(5):808-11. PubMed ID: 15010523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behçet's disease: a case report.
    Hassard PV; Binder SW; Nelson V; Vasiliauskas EA
    Gastroenterology; 2001 Mar; 120(4):995-9. PubMed ID: 11231954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of Behçet's disease with various gastrointestinal findings.
    Tominaga K; Kamimura K; Takahashi K; Yokoyama J; Terai S
    Clin J Gastroenterol; 2018 Oct; 11(5):354-358. PubMed ID: 29667077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractoriness of intestinal Behçet's disease with myelodysplastic syndrome involving trisomy 8 to medical therapies - our case experience and review of the literature.
    Toyonaga T; Nakase H; Matsuura M; Minami N; Yamada S; Honzawa Y; Hukata N; Yoshino T; Chiba T; Okazaki K
    Digestion; 2013; 88(4):217-21. PubMed ID: 24247154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mimicry between intestinal Behçet's disease and inflammatory bowel disease.
    Rodrigues-Pinto E; Magro F; Pimenta S; Guimarães J; Macedo G
    J Crohns Colitis; 2014 Jul; 8(7):714-5. PubMed ID: 24389388
    [No Abstract]   [Full Text] [Related]  

  • 10. Gastrointestinal Behçet's disease: Manifestations, diagnosis, and management.
    Manuelyan Z; Butt E; Parupudi S
    Dis Mon; 2024 Jan; 70(1S):101674. PubMed ID: 38185603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients.
    Vallet H; Riviere S; Sanna A; Deroux A; Moulis G; Addimanda O; Salvarani C; Lambert M; Bielefeld P; Seve P; Sibilia J; Pasquali J; Fraison J; Marie I; Perard L; Bouillet L; Cohen F; Sene D; Schoindre Y; Lidove O; Le Hoang P; Hachulla E; Fain O; Mariette X; Papo T; Wechsler B; Bodaghi B; Rigon MR; Cacoub P; Saadoun D;
    J Autoimmun; 2015 Aug; 62():67-74. PubMed ID: 26162757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report.
    Gulli S; Arrigo C; Bocchino L; Morgante L; Sangari D; Castagna I; Bagnato GF
    BMC Musculoskelet Disord; 2003 Aug; 4():19. PubMed ID: 12946278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thalidomide and ulcerative colitis in Behçet's disease].
    Patey O; Charasz N; Roucayrol AM; Malkin JE; Lafaix C
    Gastroenterol Clin Biol; 1989 Jan; 13(1):104. PubMed ID: 2925035
    [No Abstract]   [Full Text] [Related]  

  • 14. Intestinal Behçet's Disease: A True Inflammatory Bowel Disease or Merely an Intestinal Complication of Systemic Vasculitis?
    Kim DH; Cheon JH
    Yonsei Med J; 2016 Jan; 57(1):22-32. PubMed ID: 26632379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late-onset Behçet's disease does not correlate with indolent clinical course: report of seven Taiwanese patients.
    Tsai J; Chen GS; Lu YW; Wu CS; Lan CC
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):596-600. PubMed ID: 18266686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etiopathogenesis of Behcet's disease.
    Mendoza-Pinto C; García-Carrasco M; Jiménez-Hernández M; Jiménez Hernández C; Riebeling-Navarro C; Nava Zavala A; Vera Recabarren M; Espinosa G; Jara Quezada J; Cervera R
    Autoimmun Rev; 2010 Feb; 9(4):241-5. PubMed ID: 19879978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor necrosis factor monoclonal antibody therapy in a woman with severe Adamantiades-Behçet's disease.
    Behrens F; Zollner T; Moeller B; Kaltwasser JP; Kaufmann R; Ochsendorf FR
    Adv Exp Med Biol; 2003; 528():561-2. PubMed ID: 12918764
    [No Abstract]   [Full Text] [Related]  

  • 18. Managing the symptoms of Behçet's disease.
    Evereklioglu C
    Expert Opin Pharmacother; 2004 Feb; 5(2):317-28. PubMed ID: 14996628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of ulcerative colitis and Crohn's disease with monoclonal antibody].
    Asakura H
    Nihon Rinsho; 2002 Mar; 60(3):531-8. PubMed ID: 11904969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behçet's disease: New insights into pathophysiology, clinical features and treatment options.
    Greco A; De Virgilio A; Ralli M; Ciofalo A; Mancini P; Attanasio G; de Vincentiis M; Lambiase A
    Autoimmun Rev; 2018 Jun; 17(6):567-575. PubMed ID: 29631062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.